Last updated on October 2018

Rainbow Extension Study

Brief description of study

The purpose of this study is to evaluate the long term efficacy and safety of intravitreal ranibizumab compared with laser ablation therapy in patients who were treated for retinopathy of prematurity (ROP) in the core study CRFB002H2301

Clinical Study Identifier: NCT02640664

Find a site near you

Start Over

Novartis Investigative Site

Sumida-ku, Japan
  Connect »

Novartis Investigative Site

Toshima-ku, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.